Markets.com Logo
markets.com

ONCT

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

ONCT.US represents the common stock of Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel therapies for cancers with critical unmet medical needs. Oncternal's pipeline includes product candidates targeting receptor tyrosine kinases and other pathways implicated in cancer development. The company's efforts primarily center on developing treatments for hematologic malignancies and solid tumors. Investors in ONCT.US are exposed to the risks and potential rewards associated with biotechnology drug development, including clinical trial outcomes, regulatory approvals, and market adoption.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

Clinical Trial Results: Positive data boosts confidence, driving demand and price up. Negative or inconclusive results can cause price declines.

Regulatory Approvals: FDA approval of ONCT's drugs significantly increases market potential and stock price. Delays or rejections negatively impact the price.

Market Sentiment: General investor optimism or pessimism towards biotech stocks can influence ONCT's price, even without company-specific news.

Competition: Advances by competitors in similar therapeutic areas can negatively affect ONCT's market share and stock value.

Financial Performance: Strong cash position and effective spending can reassure investors. Poor financial health may lead to concerns about future viability.

Partnerships & Collaborations: Agreements with larger pharmaceutical companies often signal validation of ONCT's technology, increasing investor confidence and price.

People Also Watch

Markets

    Latest news

    Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

    Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

    Julian Parker|--
    McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

    McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

    Julian Parker|--
    Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

    Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

    Julian Parker|--

    Latest Education Articles

    Risk Management 101

    Risk Management 101

    Julian Parker|--
    Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

    Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

    Julian Parker|--
    Gold Scalping Strategy: How Scalping XAU/USD Works

    Gold Scalping Strategy: How Scalping XAU/USD Works

    Julian Parker|--
    Recommended Topics
    markets.com